The absence of the ARID1A variant in the diagnostic lung biopsy suggests that it most likely drove later tumor progression and was not an initiating driver variant, despite being identified as a driver in other cancer types and being recurrently detected in previous lung carcinoid studies (6, 39). The gene discussed is ARID1A; the disease is neoplasm.